CPL @1098 (96.6%) on 21-jan-2018 [ "Drug interactions of _" "world side effects of _" "Use Clinical studies of _" "common drug interactions for _" "Mothers It is not known whether _" "Geriatric Use Clinical studies of _" "real world side effects of _" "violative promotional materials for _" ] using infergen
SEAL @23 (87.5%) on 19-jan-2010 [ 123 ] using infergen
SEAL @175 (57.9%) on 09-dec-2010 [ 12 ] using infergen
MBL @1054 (93.8%) on 02-may-2017 [ Promotion of drug:infergen drughassideeffect disease:side_effects ]
CPL @1112 (56.6%) on 19-jul-2018 [ "_ is the third drug" "_ was not mutagenic" "Drug interactions of _" "world side effects of _" "Use Clinical studies of _" "common drug interactions for _" "Mothers It is not known whether _" "Geriatric Use Clinical studies of _" "drug called _" "post-approval use of _" "real world side effects of _" "Alpha interferons , including _" "violative promotional materials for _" "daily shots of _" ] using infergen